Stocksigma LogoStocksigma Logo

Novartis India FY26 BRSR: Operational Metrics, Tax Disputes, and ESG Highlights

Novartis India reported FY26 (Apr'25-Mar'26) turnover of INR 3,543.4 Mn and net worth of INR 8,178.3 Mn from its pure-play pharma trading operations

Novartis India FY26 BRSR: Operational Metrics, Tax Disputes, and ESG Highlights

Novartis India Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 10:38 pm

Novartis India FY26 BRSR: Operational Metrics, Tax Disputes, and ESG Highlights Novartis India reported FY26 (Apr'25-Mar'26) turnover of INR 3,543.4 Mn and net worth of INR 8,178.3 Mn from its pure-play pharma trading operations. Material contingencies include an appealed INR 33.83 Mn draft income tax order regarding transfer pricing and an INR 102.8 Mn TDS demand. Operationally, the firm recorded one forced product recall by Karnataka authorities. Environmentally, a strategic logistics shift from air to surface freight dramatically reduced Scope 2 emissions to 12.3 metric tonnes from 277.4 metric tonnes YoY. Zero data breaches were reported during the period.

Original exchange filing (PDF)

More announcements from Novartis India Ltd

All Novartis India Ltd announcements